About
Ming Hsieh has served on Fortinet's Board of Directors since April 2013 and chairs the Governance and Social Responsibility Committee. Since September 2012 he has been Chairman and Chief Executive Officer of Fulgent Therapeutics Inc., a cancer drug research and development company.
From October 2010 to June 2012 he served as President of 3M Cogent following 3M's 2010 acquisition of Cogent, Inc., which Mr. Hsieh had founded in 1990 and led as CEO, President and Chairman. Earlier he was a research and development engineer at International Rectifier Corporation. He holds B.S.E.E. and M.S.E.E. degrees from the University of Southern California.
Roles
Fortinet, Inc.
Director (Chair, Governance and Social Responsibility Committee) · Current role
2013–present
3M Cogent, Inc.
President · Following 3M's acquisition of Cogent, Inc. in 2010.
October 2010 - June 2012
Cogent, Inc.
Founder, Chief Executive Officer, President and Chairman · Founded Cogent in 1990; a provider of biometric identification solutions.
—
International Rectifier Corporation
Research and development engineer
1985 - 1987
3M Cogent
President · Following the 2010 acquisition of Cogent, Inc.
—
Cogent, Inc.
Founder · Founded in 1990.
—
External Roles
Fulgent Therapeutics Inc.
Chairman and Chief Executive Officer
September 2012 - present
Director Compensation
FY 2025
Fees earned or paid in cash
$83,772